United States · Bill · S
S. 36 (114th)
Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015
Introduced
6 January 2015
Last action
6 January 2015 · Introduced
Status
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S19)
Sponsors
Sen. Feinstein, Dianne [D-CA], Jeanne Shaheen, Sen. Ayotte, Kelly [R-NH], Charles Schumer, Richard Blumenthal, Amy Klobuchar, Rep. Boxer, Barbara [D-CA-6], Sen. Portman, Rob [R-OH], Sheldon Whitehouse, Sen. Franken, Al [D-MN], Edward Markey, Kirsten Gillibrand, Sen. Manchin, Joe, III [I-WV]
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015 Amends the Controlled Substances Act to include in the definition of a "controlled substance analogue" a substance designated as such by the Controlled Substance Analogue Committee (established by this Act). Directs the Attorney General to establish such Committee as an interagency committee headed by the Administrator of the Drug Enforcement Administration (DEA) and comprised of scientific experts in the fields of chemistry and pharmacology from DEA, the National Institute on Drug Abuse, the Centers for Disease Control and Prevention, and any other federal agency determined by the Attorney General to be appropriate. Requires the Committee to designate, and establish and maintain a list of, controlled substance analogues determined to be similar to a schedule I or II controlled substance in either chemical structure or predictive effect on the body in such a manner as to make it likely that the substance will, or can be reasonably expected to, have a potential for abuse. Directs the Administrator to publish a description of each designation made by the Committee. Amends the Controlled Substances Import and Export Act to prohibit the importation of any controlled substance analogue except pursuant to such notification or declaration as the Attorney General may prescribe. Directs the U.S. Sentencing Commission to review and, if appropriate, amend the federal sentencing guidelines and policy statements to ensure that they provide adequate penalties for any offense involving the unlawful manufacturing, importing, exporting, or trafficking of controlled substance analogues and similar offenses.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
6 January 2015
Introduced
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S19)
Source: IntroReferral
6 January 2015
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 6 January 2015 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 6 January 2015
Introduced in Senate (PDF)
Introduced in Senate · EN · 6 January 2015
Introduced in Senate
summary · EN · 6 January 2015
Sponsors
- Sen. Feinstein, Dianne [D-CA] · D · Sponsor
- Jeanne Shaheen · D · Sponsor
- Sen. Ayotte, Kelly [R-NH] · R · Sponsor
- Charles Schumer · D · Sponsor
- Richard Blumenthal · D · Sponsor
- Amy Klobuchar · D · Sponsor
- Rep. Boxer, Barbara [D-CA-6] · D · Sponsor
- Sen. Portman, Rob [R-OH] · R · Sponsor
- Sheldon Whitehouse · D · Sponsor
- Sen. Franken, Al [D-MN] · D · Cosponsor
- Edward Markey · D · Cosponsor
- Kirsten Gillibrand · D · Cosponsor
- Sen. Manchin, Joe, III [I-WV] · D · Cosponsor
- · ssju00 · Standing
Related records
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/senate-bill/36
- Open data entity: https://api.congress.gov/v3/bill/114/s/36
- us · 114-s-36 · source updated 10 August 2026